These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7609588)

  • 21. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease.
    Tsai JJ; Lin HJ
    Gastrointest Endosc; 2010 Jul; 72(1):223-4; author reply 224-5. PubMed ID: 20620284
    [No Abstract]   [Full Text] [Related]  

  • 22. [Conservative treatment of ulcer hemorrhage with histamine H2 antagonists].
    Grigor'ev PI; Grinberg AA; Toguzova DA; Iakovenko AV; Lopatina IV
    Khirurgiia (Mosk); 1997; (5):63-5. PubMed ID: 9297029
    [No Abstract]   [Full Text] [Related]  

  • 23. Omeprazole versus ranitidine plus somatostatin in the treatment of severe gastroduodenal bleeding: a prospective, randomized, controlled trial.
    Goletti O; Sidoti F; Lippolis PV; De Negri F; Cavina E
    Ital J Gastroenterol; 1994 Mar; 26(2):72-4. PubMed ID: 7913348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug treatment of bleeding peptic ulcers].
    Havelund T; Laursen LS; Lauritsen K
    Ugeskr Laeger; 1987 Mar; 149(11):707-10. PubMed ID: 2883748
    [No Abstract]   [Full Text] [Related]  

  • 26. Does drug therapy prevent recurrent bleeding from peptic ulcers?
    Drug Ther Bull; 1984 Nov; 22(23):90-2. PubMed ID: 6149113
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
    Ozawa T; Yoshikawa N; Tomita T; Akita Y; Mitamura K
    J Gastroenterol; 2003; 38(9):844-8. PubMed ID: 14564629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study.
    Simon-Rudler M; Massard J; Bernard-Chabert B; DI Martino V; Ratziu V; Poynard T; Thabut D
    Aliment Pharmacol Ther; 2007 Apr; 25(8):949-54. PubMed ID: 17402999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [24-hour gastric pH profile with 2 x 20 mg and 2 x 40 mg omeprazole in patients with Helicobacter pylori-associated gastroduodenal ulcer disease].
    Labenz J; Jorias I; Sollböhmer M; Peitz U; Stolte M; Börsch G
    Z Gastroenterol; 1994 Aug; 32(8):436-40. PubMed ID: 7975785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Peptic ulcer: changing indications for gastric resection during the last 15 years].
    Della Beffa V; Carelli-Basile A; Leli R; Fontana D
    Minerva Chir; 1994 Nov; 49(11):1065-9. PubMed ID: 7708225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA
    Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
    [No Abstract]   [Full Text] [Related]  

  • 37. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy and prevention of gastroduodenal ulcer bleeding by somatostatin, secretin or cimetidine.
    Gyr K
    Hepatogastroenterology; 1981 Dec; 28(6):286-7. PubMed ID: 6124496
    [No Abstract]   [Full Text] [Related]  

  • 39. Upper gastrointestinal bleeding: the trials of trials.
    Langman MJ
    Gut; 1985 Mar; 26(3):217-20. PubMed ID: 2857676
    [No Abstract]   [Full Text] [Related]  

  • 40. Recurrent ulcer bleeding: is intravenous omeprazole the solution?
    Nehme O; Barkin JS
    Am J Gastroenterol; 2001 Feb; 96(2):594-5. PubMed ID: 11232716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.